Cargando…

A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy

BACKGROUND: Accumulating evidence has suggested a link between adipokines and diabetic retinopathy (DR). This study is aimed at investigating the risk factors for sight-threatening DR (STDR) and establishing a prognostic model for predicting STDR among a high-risk population of patients with type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yaxin, Cao, Bin, Li, Kun, Xu, Yongsong, Zhao, Wenying, Zhao, Dong, Ke, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620016/
https://www.ncbi.nlm.nih.gov/pubmed/37920605
http://dx.doi.org/10.1155/2023/8831609
_version_ 1785130116825743360
author An, Yaxin
Cao, Bin
Li, Kun
Xu, Yongsong
Zhao, Wenying
Zhao, Dong
Ke, Jing
author_facet An, Yaxin
Cao, Bin
Li, Kun
Xu, Yongsong
Zhao, Wenying
Zhao, Dong
Ke, Jing
author_sort An, Yaxin
collection PubMed
description BACKGROUND: Accumulating evidence has suggested a link between adipokines and diabetic retinopathy (DR). This study is aimed at investigating the risk factors for sight-threatening DR (STDR) and establishing a prognostic model for predicting STDR among a high-risk population of patients with type 2 diabetes mellitus (T2DM). METHODS: Plasma concentrations of adipokines were determined by enzyme-linked immunosorbent assay. In the case-control set, principal component analysis (PCA) was performed to select optimal predictive cytokines for STDR, involving severe nonproliferative DR (NPDR) and proliferative DR. Support vector machine (SVM) was used to examine the possible combination of baseline plasma adipokines to discriminate the patients with mild NPDR who will later develop STDR. An individual prospective cohort with a follow-up period of 3 years was used for the external validation. RESULTS: In both training and testing sets, involving 306 patients with T2DM, median levels of plasma adiponectin (APN), leptin, and fatty acid-binding protein 4 (FABP4) were significantly higher in the STDR group than those in mild NPDR. Except for adipsin, the other three adipokines, FABP4, APN, and leptin, were selected by PCA and integrated into SVM. The accuracy of the multivariate SVM classification model was acceptable in both the training set (AUC = 0.81, sensitivity = 71%, and specificity = 91%) and the testing set (AUC = 0.77, sensitivity = 61%, and specificity = 92%). 110 T2DM patients with mild NPDR, the high-risk population of STDR, were enrolled for external validation. Based on the SVM, the risk of each patient was calculated. More STDR occurred in the high-risk group than in the low-risk group, which were grouped by the median value of APN, FABP4, and leptin, respectively. The model was validated in an individual cohort using SVM with the AUC, sensitivity, and specificity reaching 0.77, 64%, and 91%, respectively. CONCLUSIONS: Adiponectin, leptin, and FABP4 were demonstrated to be associated with the severity of DR and maybe good predictors for STDR, suggesting that adipokines may play an important role in the pathophysiology of DR development.
format Online
Article
Text
id pubmed-10620016
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-106200162023-11-02 A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy An, Yaxin Cao, Bin Li, Kun Xu, Yongsong Zhao, Wenying Zhao, Dong Ke, Jing J Diabetes Res Research Article BACKGROUND: Accumulating evidence has suggested a link between adipokines and diabetic retinopathy (DR). This study is aimed at investigating the risk factors for sight-threatening DR (STDR) and establishing a prognostic model for predicting STDR among a high-risk population of patients with type 2 diabetes mellitus (T2DM). METHODS: Plasma concentrations of adipokines were determined by enzyme-linked immunosorbent assay. In the case-control set, principal component analysis (PCA) was performed to select optimal predictive cytokines for STDR, involving severe nonproliferative DR (NPDR) and proliferative DR. Support vector machine (SVM) was used to examine the possible combination of baseline plasma adipokines to discriminate the patients with mild NPDR who will later develop STDR. An individual prospective cohort with a follow-up period of 3 years was used for the external validation. RESULTS: In both training and testing sets, involving 306 patients with T2DM, median levels of plasma adiponectin (APN), leptin, and fatty acid-binding protein 4 (FABP4) were significantly higher in the STDR group than those in mild NPDR. Except for adipsin, the other three adipokines, FABP4, APN, and leptin, were selected by PCA and integrated into SVM. The accuracy of the multivariate SVM classification model was acceptable in both the training set (AUC = 0.81, sensitivity = 71%, and specificity = 91%) and the testing set (AUC = 0.77, sensitivity = 61%, and specificity = 92%). 110 T2DM patients with mild NPDR, the high-risk population of STDR, were enrolled for external validation. Based on the SVM, the risk of each patient was calculated. More STDR occurred in the high-risk group than in the low-risk group, which were grouped by the median value of APN, FABP4, and leptin, respectively. The model was validated in an individual cohort using SVM with the AUC, sensitivity, and specificity reaching 0.77, 64%, and 91%, respectively. CONCLUSIONS: Adiponectin, leptin, and FABP4 were demonstrated to be associated with the severity of DR and maybe good predictors for STDR, suggesting that adipokines may play an important role in the pathophysiology of DR development. Hindawi 2023-10-25 /pmc/articles/PMC10620016/ /pubmed/37920605 http://dx.doi.org/10.1155/2023/8831609 Text en Copyright © 2023 Yaxin An et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
An, Yaxin
Cao, Bin
Li, Kun
Xu, Yongsong
Zhao, Wenying
Zhao, Dong
Ke, Jing
A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy
title A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy
title_full A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy
title_fullStr A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy
title_full_unstemmed A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy
title_short A Prediction Model for Sight-Threatening Diabetic Retinopathy Based on Plasma Adipokines among Patients with Mild Diabetic Retinopathy
title_sort prediction model for sight-threatening diabetic retinopathy based on plasma adipokines among patients with mild diabetic retinopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620016/
https://www.ncbi.nlm.nih.gov/pubmed/37920605
http://dx.doi.org/10.1155/2023/8831609
work_keys_str_mv AT anyaxin apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT caobin apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT likun apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT xuyongsong apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT zhaowenying apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT zhaodong apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT kejing apredictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT anyaxin predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT caobin predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT likun predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT xuyongsong predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT zhaowenying predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT zhaodong predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy
AT kejing predictionmodelforsightthreateningdiabeticretinopathybasedonplasmaadipokinesamongpatientswithmilddiabeticretinopathy